{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:48:14Z","timestamp":1789937294730,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009397","name":"Eberhard Karls University T\u00fcbingen Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jns.2024.123213","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T23:09:46Z","timestamp":1725404986000},"page":"123213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Myositis -specific and -associated antibodies in neurological disorders - A retrospective study of 727 patients"],"prefix":"10.1016","volume":"466","author":[{"given":"Benedict","family":"Kleiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus C.","family":"Kowarik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Armbruster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Marquetand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.123213_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jns.2024.123213_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","volume":"101","author":"Betteridge","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jns.2024.123213_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","article-title":"Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera","volume":"433","author":"Cavazzana","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jns.2024.123213_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112661","article-title":"Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies","volume":"474","author":"Cavazzana","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jns.2024.123213_bb0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0b013e32833f8f72","article-title":"Neurologists are from Mars. Rheumatologists are from Venus: differences in approach to classifying the idiopathic inflammatory myopathies","volume":"22","author":"Christopher-Stine","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2024.123213_bb0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00415-005-0683-5","article-title":"High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders","volume":"252","author":"Hengstman","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2024.123213_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2018.1521185","article-title":"Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists","volume":"29","author":"Kohsaka","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jns.2024.123213_bb0040","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1136\/annrheumdis-2017-212709","article-title":"Response to: \u20182017 EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?\u2019 by Malaviya","volume":"77","author":"Lundberg","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2024.123213_bb0045","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2024.123213_bb0050","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000172","article-title":"Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease","volume":"2","author":"Mammen","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2024.123213_bb0055","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2024.123213_bb0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","article-title":"International guideline for idiopathic inflammatory myopathy-associated cancer screening: an international myositis assessment and clinical studies group (IMACS) initiative","volume":"19","author":"Oldroyd","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jns.2024.123213_bb0065","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/ar4207","article-title":"Implications in the difference of anti-Mi-2 and -p155\/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara","volume":"15","author":"Petri","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jns.2024.123213_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2019.100013","article-title":"Frequencies and clinical associations of myositis-related antibodies in the Netherlands: a one-year survey of all Dutch patients","volume":"2","author":"Platteel","year":"2019","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jns.2024.123213_bb0075","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/jcla.21948","article-title":"A new immunodot assay for multiplex detection of autoantibodies in a cohort of Italian patients with idiopathic inflammatory myopathies","volume":"30","author":"Tampoia","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jns.2024.123213_bb0080","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/keaa021","article-title":"The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity","volume":"59","author":"Tansley","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jns.2024.123213_bb0085","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/rheumatology\/kez253","article-title":"Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria","volume":"58","author":"To","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jns.2024.123213_bb0090","series-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","article-title":"Myositissyndrome, S2k-Leitlinie","author":"Wiendl","year":"2022"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:05:11Z","timestamp":1741064711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24003484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":18,"alternative-id":["S0022510X24003484"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123213","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myositis -specific and -associated antibodies in neurological disorders - A retrospective study of 727 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123213"}}